pyrimidine has been researched along with Malignant Melanoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fandzloch, M; Gubernator, J; Jaromin, A; Lewińska, A; Sitkowski, J; Wiśniewska, J; Wojtczak, A; Zaremba-Czogalla, M; Łakomska, I | 1 |
| Edwards, L; Filipp, FV; Gupta, R | 1 |
| Chung, JY; Hah, JM; Kim, H; Lee, J; Oh, CH; Sim, T; Yoo, KH; Yu, H | 1 |
| BYCHENKOVA, MN; POLKINA, RI; ZALESSKAIA, LI | 1 |
| BYCHENKOVA, M; POLKINA, R; ZALESSKAYA, L | 1 |
| Rew, DA; Wilson, GD | 1 |
1 review(s) available for pyrimidine and Malignant Melanoma
| Article | Year |
|---|---|
Cell production rates in human tissues and tumours and their significance. Part II: clinical data.
Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Division; Central Nervous System Neoplasms; DNA; Esophageal Neoplasms; Female; Flow Cytometry; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Head and Neck Neoplasms; Hematologic Neoplasms; Humans; Lasers; Lung Neoplasms; Melanoma; Neoplasms; Prognosis; Pyrimidines; S Phase; Time Factors | 2000 |
5 other study(ies) available for pyrimidine and Malignant Melanoma
| Article | Year |
|---|---|
Nanoencapsulation of a ruthenium(ii) complex with triazolopyrimidine in liposomes as a tool for improving its anticancer activity against melanoma cell lines.
Topics: Antineoplastic Agents; Capsules; Cell Line, Tumor; Coordination Complexes; Humans; Hydrophobic and Hydrophilic Interactions; Liposomes; Melanoma; Nanostructures; Pyrimidines; Ruthenium; Triazoles | 2020 |
Hypermutation of DPYD Deregulates Pyrimidine Metabolism and Promotes Malignant Progression.
Topics: Binding Sites; Dihydrouracil Dehydrogenase (NADP); Disease Progression; Humans; Melanoma; Models, Molecular; Mutation; Pyrimidines; Skin Neoplasms; Systems Biology | 2016 |
Discovery and initial SAR of pyrimidin-4-yl-1H-imidazole derivatives with antiproliferative activity against melanoma cell lines.
Topics: Antineoplastic Agents; Benzenesulfonates; Binding Sites; Cell Line, Tumor; Crystallography, X-Ray; Drug Discovery; Humans; Imidazoles; Melanoma; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Protein Kinases; Proto-Oncogene Proteins c-raf; Pyridines; Pyrimidines; Sorafenib; Structure-Activity Relationship | 2010 |
[RADIOSENSITIZATION OF INOCULATED TUMORS WITH SOME PYRIMIDINE DERIVATIVES].
Topics: Animals; Carcinoma, Ehrlich Tumor; Melanoma; Mice; Neoplasms; Pyrimidines; Research; Sarcoma 180 | 1963 |
RADIOSENSITIZATION OF TUMORS WITH PYRIMIDINE DERIVATIVES.
Topics: Animals; Carcinoma, Ehrlich Tumor; Melanoma; Mice; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Pharmacology; Pyrimidines; Radiation Effects; Research; Skin Neoplasms; Uracil | 1964 |